Pfizer Inc.
Method of treatment of Chronic Low Back Pain
Last updated:
Abstract:
The present invention relates to the treatment of chronic low back pain with an anti-nerve growth factor (NGF) antibody.
Status:
Application
Type:
Utility
Filling date:
14 Feb 2020
Issue date:
5 May 2022